Valentina V. Iuzzolino

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Phosphorylated TDP-43 Pathology in Skin and Muscle Tissue of Patients With Amyotrophic Lateral Sclerosis.

Phosphorylated TDP-43 Pathology in Skin and Muscle Tissue of Patients With Amyotrophic Lateral Sclerosis.

Journal: Neurology

Published: April 30, 2026

Elevated plasma sTREM2 reflects microglial activation but lacks diagnostic and clinical relevance in amyotrophic lateral sclerosis.

Elevated plasma sTREM2 reflects microglial activation but lacks diagnostic and clinical relevance in amyotrophic lateral sclerosis.

Journal: Neurobiology of disease

Published: March 23, 2026

Plasma NfL, GFAP and pTau181 define distinct biological axes in amyotrophic lateral sclerosis.

Plasma NfL, GFAP and pTau181 define distinct biological axes in amyotrophic lateral sclerosis.

Journal: Neurobiology of disease

Published: March 02, 2026

The Dysphagia Outcome and Severity Scale (DOSS) and non-instrumental swallowing measures in amyotrophic lateral sclerosis.

The Dysphagia Outcome and Severity Scale (DOSS) and non-instrumental swallowing measures in amyotrophic lateral sclerosis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 28, 2026

siRNA for REST ameliorates symptoms in ALS mice and serum REST predicts disease prognosis and survival in ALS patients.

siRNA for REST ameliorates symptoms in ALS mice and serum REST predicts disease prognosis and survival in ALS patients.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 12, 2025

Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis.

Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis.

Journal: Annals of neurology

Published: May 04, 2025

In vivo assessment of GABAergic inhibition and glutamate facilitation in treatment-resistant schizophrenia: a TMS study integrating clinical, cognitive, and neurophysiological evaluations.

In vivo assessment of GABAergic inhibition and glutamate facilitation in treatment-resistant schizophrenia: a TMS study integrating clinical, cognitive, and neurophysiological evaluations.

Journal: Schizophrenia (Heidelberg, Germany)

Published: March 26, 2025

Identifying Mild Behavioral and Neurocognitive Impairment in Amyotrophic Lateral Sclerosis (MBNI-ALS) Provides Key Prognostic Insights.

Identifying Mild Behavioral and Neurocognitive Impairment in Amyotrophic Lateral Sclerosis (MBNI-ALS) Provides Key Prognostic Insights.

Journal: European journal of neurology

Published: February 15, 2025

Mapping motor and extra-motor gray and white matter changes in ALS: a comprehensive review of MRI insights.

Mapping motor and extra-motor gray and white matter changes in ALS: a comprehensive review of MRI insights.

Journal: Neuroradiology

Published: November 11, 2024

Clinical efficacy of low-dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2.

Clinical efficacy of low-dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2.

Journal: Epilepsia open

Published: May 30, 2024

Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis.

Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis.

Journal: European journal of neurology

Published: March 23, 2024

Voice signals database of ALS patients with different dysarthria severity and healthy controls.

Voice signals database of ALS patients with different dysarthria severity and healthy controls.

Journal: Scientific data

Published: January 17, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026